ABVC BIOPHARMA, INC. 10-Q filing
Filed 2026-05-18 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001213900-26-058104
- Form type
- 10-Q
- CIK
- 0001173313
- Primary document
- https://www.sec.gov/Archives/edgar/data/1173313/000121390026058104/ea0290931-10q_abvc.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ABVC BIOPHARMA, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-1.6M | - | - |
| Net Income | $-1.6M | - | - |
| Eps Basic | -0.06 | - | - |
| Eps Diluted | -0.06 | - | - |
| Cash And Equivalents | $140,324 | - | - |
| Total Assets | $19.7M | - | - |
| Total Liabilities | $6.9M | - | - |
| Shareholders Equity | $10.8M | - | - |
| Operating Cash Flow | $-894,243 | - | - |